Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control – a retrospective United States database analysis
FP/SAL and BUD/FOR were similarly effective for asthma control in real-world settings, while FP/SAL was generally associated with greater medication adherence, a key factor for long-term control.
Authors
- Bilun Gemicioğlu (ORCID: https://orcid.org/0000-0001-5953-4881)
- Nicola A. Hanania (ORCID: https://orcid.org/0000-0003-3087-9530)
- Watchara Boonsawat (ORCID: https://orcid.org/0000-0003-0143-2609)
- Adrián Rendón (ORCID: https://orcid.org/0000-0001-8973-4024)
- Mohamed Hamouda (ORCID: https://orcid.org/0000-0001-7474-6487)
- Nnaemeka U. Odo (ORCID: https://orcid.org/0000-0002-9153-4600)
- Richard H. Stanford (ORCID: https://orcid.org/0000-0001-5795-1147)
- Leandro Genehr Fritscher (ORCID: https://orcid.org/0000-0002-6168-3808)
- Anurita Mamjudar
Institutions
- Hamdan Bin Mohammed Smart University (AE)
- Universidad Autónoma de Nuevo León (MX)
- Khon Kaen University (TH)
- Baylor College of Medicine (US)
- Istanbul University-Cerrahpaşa (TR)
- Telesage (United States) (US)
- Optum (United States) (US)
- Hospital Universitario Dr José Eleuterio Gonzalez (MX)
- GlaxoSmithKline (Germany) (DE)
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Publication Details
- Journal
- Respiratory Medicine
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1016/j.rmed.2025.108172
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- GlaxoSmithKline
- Life Sciences, University of California, Los Angeles